田要美｜四川轻化工大学｜学者主页

2024

Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer

Jie Xu, Yaomei Tian, Binyan Zhao, Die Hu, Siwen Wu, Jing Ma, Li Yang

Molecular Biomedicine

DOI

2024

Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges

Jie Xu, Yaomei Tian, Die Hu, Xi Yan, Li Yang

MedComm - Oncology

DOI

2023

A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy

Rui Zhang, Lin Tang, Yu-Si Wang, Yaomei Tian, Siwen Wu, Bailing Zhou, Chunyan Dong, Binyan Zhao, Yu-Ling Yang, Daoyuan Xie, Li Yang

Advancement of science

DOI

2023

Oncolytic viral therapy as promising immunotherapy against glioma

Die Hu, Yaomei Tian, Jie Xu, Daoyuan Xie, Yu-Si Wang, Mo-Han Liu, Yuan-Da Wang, Li Yang

MedComm – Future Medicine

DOI

2023

Combining an adenovirus encoding human endostatin and PD‐1 blockade enhanced antitumor immune activity

Yaomei Tian, Qie Hu, Rui Zhang, Bailing Zhou, Daoyuan Xie, Yuan-Da Wang, Li Yang

MedComm - Oncology

DOI

2023

Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy

Daoyuan Xie, Yaomei Tian, Die Hu, Yuan-Da Wang, Yu-Ling Yang, Bailing Zhou, Rui Zhang, Zhixiang Ren, Mo-Han Liu, Jie Xu, Chunyan Dong, Binyan Zhao, Li Yang

Signal Transduction and Targeted Therapy

DOI

2022

Development of therapeutic vaccines for the treatment of diseases

Yaomei Tian, Die Hu, Yu-Hua Li, Li Yang

Molecular Biomedicine

DOI

2022

Engineering strategies to enhance oncolytic viruses in cancer immunotherapy

Yaomei Tian, Daoyuan Xie, Li Yang

Signal Transduction and Targeted Therapy

DOI

2021

Sustained and targeted delivery of siRNA/DP7‐C nanoparticles from injectable thermosensitive hydrogel for hepatocellular carcinoma therapy

Binyan Zhao, Bailing Zhou, K. Shi, Rui Zhang, Chunyan Dong, Daoyuan Xie, Lin Tang, Yaomei Tian, Z. Qian, Li Yang

Cancer Science

DOI

2021

Cholesterol modified DP7 and pantothenic acid induce dendritic cell homing to enhance the efficacy of dendritic cell vaccines

Rui Zhang, Lin Tang, Qing Li, Yaomei Tian, Binyan Zhao, Bailing Zhou, Li Yang

Molecular Biomedicine

DOI

2021

A Peptide-Based Small RNA Delivery System to Suppress Tumor Growth by Remodeling the Tumor Microenvironment.

Rui Zhang, Lin Tang, Binyan Zhao, Yaomei Tian, Bailing Zhou, Yan-Dong Mu, Li Yang

Molecular Pharmaceutics

DOI

2021

Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy.

Yu-Ling Yang, Xue-Yan Zhang, Siwen Wu, Rui Zhang, Bailing Zhou, Xiaoyu Zhang, Lin Tang, Yaomei Tian, Ke Men, Li Yang

Journal of Controlled Release

DOI

2021

Rational design of innate defense regulator peptides as tumor vaccine adjuvants

Yaomei Tian, Qiu-Yue Hu, Rui Zhang, Bailing Zhou, Daoyuan Xie, Yuan-Da Wang, Xue-Yan Zhang, Li Yang

npj Vaccines

DOI

2021

H2O2-Inactivated Salmonella typhimurium RE88 Strain as a New Cancer Vaccine Carrier: Evaluation in a Mouse Model of Cancer

Yingzi Fan, Ting-Ting Bai, Yaomei Tian, Bailing Zhou, Yuan-Da Wang, Li Yang

Drug Design, Development and Therapy

DOI

2020

DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine.

Rui Zhang, Lin Tang, Yaomei Tian, X. Ji, Qiu-Yue Hu, Bailing Zhou, Z. Ding, Heng Xu, Li Yang

Journal of Controlled Release

DOI

2020

Cholesterol-modified DP7 enhances the effect of individualized cancer immunotherapy based on neoantigens.

Rui Zhang, Lin Tang, Yaomei Tian, X. Ji, Qiu-Yue Hu, Bailing Zhou, Z. Ding, Xun-Xuan Heng, Li Yang

Biomaterials

DOI

2019

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models

Rui Zhang, Fengjiao Yuan, Y. Shu, Yaomei Tian, Bailing Zhou, Linglu Yi, Xue-Yan Zhang, Z. Ding, Heng Xu, Li Yang

Cancer Immunology and Immunotherapy

DOI

2019

Hydrogen peroxide‐inactivated bacteria induces potent humoral and cellular immune responses and releases nucleic acids

Yingzi Fan, Yan-Dong Mu, Lian Lu, Yaomei Tian, Fengjiao Yuan, Bailing Zhou, Chaoheng Yu, Zhen-Ling Wang, Xiaolu Li, Song Lei, Ying Xu, Dong-Ming Wu, Li Yang

International Immunopharmacology

DOI

2018

Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene Therapy.

Rui Zhang, Ke Men, Xue-Yan Zhang, Rong Huang, Yaomei Tian, Bailing Zhou, Chaoheng Yu, Yantai Wang, X. Ji, Qiu-Yue Hu, Li Yang

Journal of Biomedical Nanotechnology

DOI

2017

The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo

Yaomei Tian, Meng Li, Chaoheng Yu, Rui Zhang, Xue-Yan Zhang, Rong Huang, Lian Lu, Fengjiao Yuan, Yingzi Fan, Bailing Zhou, Ke Men, Heng Xu, Li Yang

OncoTarget

DOI

2017

Abstract LB-202: A novel neoepitope screening platform for generating effective and safe neoantigen-based vaccines and immunotherapeutics in a hepatocellular carcinoma model

Cheng-chi Chao, Fengjiao Yuan, Geng Liu, Guanglei Li, B. Li, Lian Lu, Yaomei Tian, Dongli Li, Bailing Zhou, Ting-Ting An, Yingzi Fan, Chongming Tom Jiang, Y. Shu, Honggang Lin, Heng Xu, Han-Suo Yang, Rui Zhang, Xue-Yan Zhang, Zhen Cheng, Rong Huang, M. Dean, Meng-Zong Ke, Xiu-Qing Zhang, Chaoheng Yu, Jian Wang, Shu-Li Cheng, Huan-Ming Yang, Yantai Wang, Yong Hou, Yu-Quan Wei, Li Yang

DOI

2016

Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces long‑lasting and balanced immune responses.

Chao Yu, Zi-chao Luo, Meng Li, Lian Lu, Zhan Li, Xiaozhe Wu, Yingzi Fan, Hai-Long Zhang, Bai-Ling Zhou, Y. Wan, Ke Men, Yaomei Tian, Shuang Chen, Fengjiao Yuan, R. Xiang, Li Yang

Molecular Medicine Reports

DOI

2014

Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2

Meng Li, Hua-Shan Shi, Yan-Dong Mu, Zi-chao Luo, Hai-Long Zhang, Y. Wan, Dong-Mei Zhang, Lian Lu, Ke Men, Yaomei Tian, Xiaozhe Wu, Xiaoyan Liu, Ying Pan, Yingzi Fan, Chaoheng Yu, Bailing Zhou, R. Xiang, Xian-Cheng Chen, Li Yang

Molecular Cancer

DOI

田要美

精选作品

期刊论文

Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer

Enhancing cancer immunotherapy and antiangiogenic therapy by regulating gut microbes: Opportunities and challenges

A Dendrimer Peptide (KK2DP7) Delivery System with Dual Functions of Lymph Node Targeting and Immune Adjuvants as a General Strategy for Cancer Immunotherapy

Oncolytic viral therapy as promising immunotherapy against glioma

Combining an adenovirus encoding human endostatin and PD‐1 blockade enhanced antitumor immune activity

Oncolytic adenoviruses expressing checkpoint inhibitors for cancer therapy

Development of therapeutic vaccines for the treatment of diseases

Engineering strategies to enhance oncolytic viruses in cancer immunotherapy

Sustained and targeted delivery of siRNA/DP7‐C nanoparticles from injectable thermosensitive hydrogel for hepatocellular carcinoma therapy

Cholesterol modified DP7 and pantothenic acid induce dendritic cell homing to enhance the efficacy of dendritic cell vaccines

A Peptide-Based Small RNA Delivery System to Suppress Tumor Growth by Remodeling the Tumor Microenvironment.

Enhanced nose-to-brain delivery of siRNA using hyaluronan-enveloped nanomicelles for glioma therapy.

Rational design of innate defense regulator peptides as tumor vaccine adjuvants

H2O2-Inactivated Salmonella typhimurium RE88 Strain as a New Cancer Vaccine Carrier: Evaluation in a Mouse Model of Cancer

DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine.

Cholesterol-modified DP7 enhances the effect of individualized cancer immunotherapy based on neoantigens.

Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models

Hydrogen peroxide‐inactivated bacteria induces potent humoral and cellular immune responses and releases nucleic acids

Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene Therapy.

The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo

Abstract LB-202: A novel neoepitope screening platform for generating effective and safe neoantigen-based vaccines and immunotherapeutics in a hepatocellular carcinoma model

Synthetic innate defense regulator peptide combination using CpG ODN as a novel adjuvant induces long‑lasting and balanced immune responses.

Effective inhibition of melanoma tumorigenesis and growth via a new complex vaccine based on NY-ESO-1-alum-polysaccharide-HH2

会议论文

OmpA结构域免疫保护功能研究

研究方向